Advertisement
Advertisement
PBH
Prestige Consumer Healthcare Inc.
46.44
USDSponsored
-0.16
-0.34%
May 19, 15:59 UTC -4
Closed
After-Market
46.43
-0.01
-0.02%
PBH Earnings Reports
Positive Surprise Ratio
PBH beat 31 of 41 last estimates.
76%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q1 27 (Revenue/ EPS)
$253.50M
/$0.93
Implied change from Q4 26 (Revenue/ EPS)
-9.84%
/-24.39%
Implied change from Q1 26 (Revenue/ EPS)
+1.59%
/-2.11%
Prestige Consumer Healthcare Inc. earnings per share and revenue
On May 13, 2026, PBH reported earnings of 1.23 USD per share (EPS) for Q4 26, missing the estimate of 1.40 USD, resulting in a -12.39% surprise. Revenue reached 281.17 million, compared to an expected 296.60 million, with a -5.20% difference. The market reacted with a +0.54% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 3 analysts forecast an EPS of 0.93 USD, with revenue projected to reach 253.50 million USD, implying an decrease of -24.39% EPS, and decrease of -9.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
Cytosorbents Corp.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.08
Surprise
-42.60%
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
Innovative Eyewear, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.37
Surprise
+22.82%
IM Cannabis Corp. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.38
Surprise
-
FAQ
What were Prestige Consumer Healthcare Inc.'s earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Prestige Consumer Healthcare Inc. reported EPS of $1.23, missing estimates by -12.39%, and revenue of $281.17M, -5.2% below expectations.
How did the market react to Prestige Consumer Healthcare Inc.'s Q4 2026 earnings?
The stock price moved up 0.54%, changed from $56.02 before the earnings release to $56.32 the day after.
When is Prestige Consumer Healthcare Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Prestige Consumer Healthcare Inc.'s next earnings report?
Based on 3
analysts, Prestige Consumer Healthcare Inc. is expected to report EPS of $0.93 and revenue of $253.50M for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement